TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ZINC SULFATE

ZINC SULFATE
Approved 1987-05-05
10
Indications
--
Phase 3 Trials
38
Years on Market

Details

Status
Prescription
First Approved
1987-05-05
Routes
INTRAVENOUS, INJECTION
Dosage Forms
SOLUTION, INJECTABLE

ZINC SULFATE Approval History

Loading approval history...

What ZINC SULFATE Treats

10 FDA approvals

Originally approved for its first indication in 1987 . Covers 10 distinct patient populations.

  • Other (10)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ZINC SULFATE FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Zinc Sulfate Injection is indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. Zinc Sulfate Injection is a trace element indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.